The Imaging Science and Cancer Biology Symposium will showcase the latest technologies and advances in imaging science and will feature world leaders in the field who will highlight current progress and the potential of imaging in cancer diagnosis and therapy.
AACI Update | June 2019
Headlines
Champion for Cures Award to Recognize Jon M. and Karen Huntsman Family
The Jon M. and Karen Huntsman family will receive AACI's 2019 Champion for Cures Award, in recognition of their significant leadership in supporting efforts to cure cancer and in inspiring others to do the same. The Huntsman family’s first major gift to cancer research came in 1993 at $10 million, followed by a $100 million gift in 1995 that formally established and named the Huntsman Cancer Institute (HCI) at the University of Utah. In all, the family has donated or inspired donations totaling $1.4 billion to cancer.
CRI Meeting Spotlight: Ciolino to Present on Changes to CCSG
AACI to Co-Host Congressional Briefing on HPV-Related Cancers
AACI is among nine partner organizations that will co-host a congressional briefing from 12:00 to 1:30 pm on Thursday, June 27. "Let's End HPV-Related Cancers" will provide an overview of the global impact of cancers related to human papillomavirus (HPV) and opportunities to reduce the burden of these cancers, both in the U.S. and worldwide.
News from the Centers
Rosen Inducted Into Association of American Physicians
City of Hope Comprehensive Cancer Center
City of Hope Provost and Chief Scientific Officer Steven T. Rosen, MD, has been inducted as a member of the Association of American Physicians (AAP). Dr. Rosen is a leader in the field of hematologic malignancies and has spent more than three decades improving treatment in myeloma, leukemia, and lymphoma.Colonna, Ley Elected to National Academy of Sciences
Siteman Cancer Center
Two physician-scientists at Washington University School of Medicine in St. Louis and Siteman Cancer Center were elected to the National Academy of Sciences, one of the highest honors that can be awarded to a U.S. scientist or engineer. Marco Colonna, MD, and Timothy J. Ley, MD, were among the 100 new members and 25 foreign associates elected to the academy this year.Urology Professor Elected to National Association
UCLA Jonsson Comprehensive Cancer Center
Christopher Saigal, MD, professor of urology in the David Geffen School of Medicine at UCLA, has been elected to the American Association of Genitourinary Surgeons in recognition of his accomplishments in the field. Dr. Saigal’s research in the field of shared decision making for prostate cancer focuses on empowering men to make informed treatment choices with which they're more satisfied.Margenthaler is President-Elect of The American Society of Breast Surgeons
Siteman Cancer Center
Julie Margenthaler, MD, a Washington University professor of surgery at Siteman Cancer Center, has been named president-elect of The American Society of Breast Surgeons. She will serve in the role until 2020, when she becomes president of the organization. Dr. Margenthaler has served as treasurer since 2017.Foundation Honors Native American Researcher
Roswell Park Comprehensive Cancer Center
Roswell Park Comprehensive Cancer Center faculty researcher Rodney Haring, PhD, MSW, has been recognized with a Research Into Action Award from the Robert Wood Johnson Foundation’s New Connections initiative. The award symbolizes what Dr. Haring has accomplished as a New Connections grantee, including a project in 2010 that looked at childhood obesity and oral health within Native American communities.AACR Taps Knudsen for Board of Directors
Sidney Kimmel Comprehensive Cancer Center at Jefferson
The members of the American Association for Cancer Research (AACR) have elected Karen E. Knudsen, PhD, executive vice president of Oncology Services and enterprise director of the Sidney Kimmel Cancer Center at Jefferson Health, to its Board of Directors. Dr. Knudsen is one of five world-renowned cancer researchers elected to the board for the 2019-2022 term.Researchers Appointed to National Scientific Leadership Roles
Huntsman Cancer Institute at the University of Utah
Huntsman Cancer Institute CEO, Mary Beckerle, PhD, and HCI’s Senior Director of Pre-Clinical Translation, Martin McMahon, PhD, have been appointed to prominent advisory group positions within the National Institutes of Health.Grant Awarded for Cancer Health Equity Center
University of Florida Health Cancer Center
The National Cancer Institute has awarded a five-year, $16 million grant to establish a cancer health equity center at the University of Florida and partner institutions. The Florida-California Cancer Research, Education, and Engagement, or CaRE2, Health Equity Center will be an interdisciplinary, intercollegiate effort involving researchers from UF, Florida A&M University, and the University of Southern California.Project to Eradicate Hepatitis C in Kentucky County Gets $15 Million Grant
UK Markey Cancer Center
With $15 million from the National Cancer Institute and the National Institute on Drug Abuse and a donation of 900 doses of a 12-week treatment from Gilead Sciences Inc., Jennifer Havens, PhD, has the goal of eradicating hepatitis C virus in Perry County.Cervical Cancer Prevention Aim of $11 Million Grant
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
A major public health initiative aimed at preventing cervical cancer in at-risk Appalachian families from Ohio, Kentucky, Virginia, and West Virginia is underway with support from an $11 million National Cancer Institute grant to OSUCCC – James.
Over $5 Million Awarded to Investigate Pediatric Obesity and Cancer-Related Co-Morbidities
VCU Massey Comprehensive Cancer Center
VCU Massey Cancer Center researcher Melanie Bean, PhD, LCP, was awarded over $5 million in grant funding by the National Institutes of Health to study factors that may impact pediatric obesity and cancer-related co-morbidities among traditionally underserved populations.Scientists Receive Grant for Lung Cancer Research
Yale Cancer Center, Yale School of Medicine
Katerina Politi, PhD, and Don Nguyen, PhD, members of the Signal Transduction Research Program at Yale Cancer Center, have received a five-year, nearly $4 million National Cancer Institute (NCI) grant to support lung cancer research. The award is to help study the relationship between drug resistance and metastasis as part of the NCI's Patient-Derived Models Consortium.$2 Million NCI Grant to Study Metastatic Bladder Cancer
Duke Cancer Institute, Duke University Medical Center
The National Cancer Institute (NCI) awarded $2.1 million to Duke Cancer Institute researchers to study plasmonic nanoparticle-mediated immunotherapy to treat metastatic bladder cancer. Co-principal investigators, Brant Inman, MD, MS, and Tuan Vo-Dinh, PhD, developed a two-pronged treatment approach utilizing nanotherapy and immunotherapy, a treatment they refer to as Synergistic Immuno Photothermal Nanotherapy (SYMPHONY), to enhance the efficacy of immunotherapy for bladder cancer.Gift Pushes Chuckstrong Tailgate Gala Past $1.8 Million
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
On a night when Chuck Pagano returned to Indianapolis, Colts owner Jim Irsay pledged $1 million to cancer research in his former coach’s honor, helping to raise more than $1.8 million to support scientists at the Indiana University Melvin and Bren Simon Cancer Center.DeLuca Foundation Grant to Fund Hematology Research Center
Yale Cancer Center, Yale School of Medicine
Yale Cancer Center and Smilow Cancer Hospital announce a five-year grant awarded by The Frederick A. DeLuca Foundation to establish The DeLuca Center for Innovation in Hematology Research. The gift will help translate groundbreaking research discoveries into practice-changing improvements in clinical care for blood cancer patients. It will also ensure detailed genetic characterization of each patient’s cancer and advance the next generation of treatments for hematologic malignancies.$1.47 Million Grant to Continue Lung Cancer Clinical Trials
UAMS Winthrop P. Rockefeller Cancer Institute
Physician-scientist Donald J. Johann Jr., MD, has been awarded a $1.47 million grant from the Food and Drug Administration to continue a clinical trial to determine if new approaches can be developed to monitor and screen for lung cancer with a blood test.Endowed Gift Establishes Katzen Family Director
GW Cancer Center
The George Washington University (GW) Cancer Center has established the Dr. Cyrus Katzen Family Director of the GW Cancer Center, thanks to a gift from GW alumnus and former Board of Trustees member Jay Katzen, MD. The gift will support the ongoing growth and expansion of the GW Cancer Center in strategic areas of clinical care, research, and education.Hennig Named Director of Oncology Advanced Practice
Duke Cancer Institute, Duke University Medical Center
Therese Hennig, MPAS, PA-C, advanced practice leader for the division of Hematologic Malignancies and Cellular Therapy, has been named director of Oncology Advanced Practice for Duke Cancer Institute. Hennig has been recognized for her clinical expertise and leadership and has been instrumental in the design of provider practice models within the division.Sociologist Promoted to Community Engagement Leadership Role
Roswell Park Comprehensive Cancer Center
Elizabeth Bouchard, PhD, has been promoted to associate director for community outreach and engagement at Roswell Park Comprehensive Cancer Center. In this new role, she will facilitate meaningful connections with area residents and partner organizations. Dr. Bouchard will work with other Roswell Park researchers and outreach specialists to take a deep dive into cancer issues that are important to Western New Yorkers.Jaffray Named Chief Technology and Digital Officer
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center has named David Jaffray, PhD, as its first chief technology and digital officer. Jaffray will oversee MD Anderson’s information services division and information security department. He will also hold a faculty appointment as professor of radiation physics with a joint appointment in imaging physics.Assistant Director of Finance, Administration Joins WVU
WVU Cancer Institute
The WVU Cancer Institute welcomes Mike Ridinger, RN, MBA, as assistant director of finance and administration and the administrator of Hematology/Oncology. Ridinger has more than 15 years of experience with health and medical systems. His background includes understanding and utilizing economic, financial, market, and industry segment data to identify key issues and implications for potential strategies and plans.Hall Named Chair of Clinical Genetics
Fox Chase Cancer Center, Temple Health
Michael Hall, MD, MS, has been named chair of the Department of Clinical Genetics at Fox Chase Cancer Center. An associate professor in the department, Dr. Hall will continue to serve in his other roles at Fox Chase, including director of Gastrointestinal Risk Assessment; and NCCN, Genetic Colorectal/Colorectal Cancer Screening Panel member.New Leader of Cancer Immunotherapy
UPMC Hillman Cancer Center
UPMC Hillman Cancer Center has appointed Jason Luke, MD, FACP, to direct the newly established Cancer Immunotherapeutics Center. A medical oncologist and clinical investigator, Dr. Luke specializes in early phase drug development for melanoma and solid tumors. He has been the lead investigator for numerous immunotherapies over the past several years.Enhanced Anticancer Compound May Allow for Precise Activation, Tracking of Treatment
Ellen and Ronald Caplan Cancer Center of The Wistar Institute
Researchers at The Wistar Institute and the University of South Florida have advanced a novel compound that specifically targets the endoplasmic reticulum stress response that is frequently hyperactivated in cancer and promotes survival of cancer cells during stressful conditions. The new compound has unique chemical properties that allow for precise activation and can be used for tracking its activity in vivo thanks to the emission of fluorescence.Learning From a Rare Disease
University of New Mexico Comprehensive Cancer Center
UNM Comprehensive Cancer Center molecular medicine scientist Hua-Ying Fan, PhD, studies the cells of people with Cockayne syndrome, who don’t live long enough to develop cancer. By studying their cells, Dr. Fan and her research team discovered the importance of a protein called CSB, which works with another protein called PARP1 to repair damaged DNA and could have implications for improving the potency of cancer drugs.Medicaid Could Save $2.6 Billion Within a Year if Just 1 Percent of Recipients Quit Smoking
UCSF Helen Diller Family Comprehensive Cancer Center
Reducing smoking, and its associated health effects, among Medicaid recipients in each state by just 1 percent would result in $2.6 billion in total Medicaid savings the following year, according to new research by UC San Francisco. The median state would save $25 million, ranging from $630.2 million in California to $2.5 million in South Dakota.New Target Found to Improve Response to Cancer Immunotherapy
University of Michigan Rogel Cancer Center
New findings suggest an unexpected path to killing cancer cells could make immunotherapy more effective. Researchers at the University of Michigan Rogel Cancer Center found that a little-understood type of cell death called ferroptosis occurs in tumor cells and plays a role in cancer immunity, suggesting the potential of targeting this pathway to improve immunotherapy treatments. Weiping Zou, MD, PhD, is senior study author.Search Progresses for Laboratory Test to Predict Spread of Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Researchers at the Johns Hopkins University and other institutions report that a new laboratory test that induces cancer cells to squeeze through narrow spaces has the potential to accurately predict which breast cancers and other solid tumors are likely to spread, or metastasize, to other sites. The team received a U.S. patent on the test, called Microfluidic Assay for quantification of Cell Invasion (MAqCI), which uses a device to assess three key features of metastasis: cancer cells’ ability to move, to compress in order to enter narrow channels, and to proliferate.'Super-Hero' Stem Cells Survive Radiation to Regrow Muscles
UCSF Helen Diller Family Comprehensive Cancer Center
UC San Francisco researchers have discovered a new type of stem cell in mouse muscles that is resistant to radiation and other forms of cellular stress. The findings have implications for improving recovery for cancer patients undergoing radiotherapy and could even lead to treatments to protect future astronauts from the ravages of deep-space radiation.Bone Cells Suppress Cancer Metastases
Sidney Kimmel Comprehensive Cancer Center at Jefferson
How can breast cancer cells from a primary tumor reach the bones when a patient is deemed "cancer free" after treatment? What allows cancer cells to remain "sleeping" in bones for up to 30 years? In a step toward answering these questions, Jefferson researcher Karen Bussard, PhD, discovered a type of bone cell that can slow the growth of cancer cells, even in triple-negative breast cancer.How Cancer Hijacks Wound Healing to Create Its Own Blood Supply
University of Virginia Cancer Center
Researchers at the University of Virginia School of Medicine have shed light on how cancers hijack the body’s natural wound-healing response to grow and spread. The researchers have identified specific processes within endothelial cells—the cells that line blood vessels—that tumors use to build out their own blood supply.Newly Discovered Protein Explains Leukemia's Treatment Resistance
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
An overactive protein complex that helps drive the development of leukemia may explain why many therapies for the cancer have proven ineffective, according to a new Northwestern Medicine study. Leonidas Platanias, MD, PhD, director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, is senior author of the study.Novel Role in Spatial Chromosome Organization Identified for Frequently Mutated Cancer Protein
Ellen and Ronald Caplan Cancer Center of The Wistar Institute
New research from The Wistar Institute sheds light on the function of the ARID1A protein, encoded by a gene that is among the most frequently mutated across human cancers. According to the study, ARID1A plays a role in the spatial organization of the genome; therefore, its loss has broad effects on global gene expression. Rugang Zhang, PhD, is the study's principal investigator.Partial Breast Irradiation Effective Option for Low-Risk Breast Cancer
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute.Study Aimed at Increasing Diversity Among Clinical Trial Participants
USC Norris Comprehensive Cancer Center
USC Norris Comprehensive Cancer Center has launched a study to determine how financial assistance for costs associated with clinical trial participation might increase enrollment, particularly among low-income patients and racial and ethnic minorities. Darcy Spicer, MD, is principal investigator on the study, known as Improving Patient Access to Cancer Clinical Trials (IMPACT).
First Direct Evidence Found That Oxidative Stress Damage Shortens Telomeres
UPMC Hillman Cancer Center
A new study from the UPMC Hillman Cancer Center provides the first evidence that oxidative stress acts directly on telomeres to speed up cellular aging. The key was a new method, developed by neighboring Carnegie Mellon University, that zeroes in on the telomeres and delivers localized free radicals—the molecular agent of oxidative stress—on command. When researchers used this tool on cultured cancer cells, they saw the telomeres break and shorten with each cell division, destabilizing the genome and preventing cells from dividing properly.Four Hallmarks of Metastasis Identified
The University of Kansas Cancer Center
Since the term "metastasis" was coined nearly 200 years ago, thousands of scientific papers have been published on the subject. A comprehensive literature review, authored by Danny Welch, PhD, seeks to summarize the metastatic research landscape and identify the distinguishing features of metastasis.New Method Opens Unexplored Realms for Liquid Biopsies
University of Michigan Rogel Cancer Center
Researchers at the University of Michigan Rogel Cancer Center have developed a new method for lifting the genetic "fingerprints" of tiny fragments of RNA found in blood plasma that are invisible to traditional methods of RNA sequencing. Muneesh Tewari, MD, PhD, is senior author of the study.Synthetic Biology Used to Target Cancer Cells While Sparing Healthy Tissue
Stanford Cancer Institute
Synthetic proteins engineered to recognize overly active biological pathways can kill cancer cells while sparing their healthy peers, according to a study by researchers at the Stanford University School of Medicine. Michael Lin, MD, PhD, is senior author.Tumor Mutations May Predict Response to Immunotherapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Checkpoint inhibitor drugs that stimulate the immune system have become a growing success story in the treatment of some cancers. But about half of patients whose tumors are marked by a large number of mutations from so-called mismatch repair genetic deficiency fail to respond to the drugs. Now, researchers from the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immnotherapy, and Memorial Sloan Kettering Cancer Center say they have found a potential explanation for the failures.Air Pollution Poses Risks for Childhood Cancer Survivors
Huntsman Cancer Institute at the University of Utah
Poor air quality days significantly increase the risk of hospitalizations for respiratory issues in young survivors of cancer, according to a study conducted by researchers at Huntsman Cancer Institute (HCI) at the University of Utah. Judy Ou, PhD, a cancer epidemiologist at HCI, is lead author on the study.Scientists Identify Genes Tied to Increased Risk of Ovarian Cancer
UCLA Jonsson Comprehensive Cancer Center
A team of researchers from UCLA’s Jonsson Comprehensive Cancer Center, Cedars-Sinai Cancer, and Dana-Farber Cancer Institute has identified 34 genes that are associated with an increased risk for developing the earliest stages of ovarian cancer. The findings will both help identify women who are at highest risk of developing ovarian cancer and pave the way for identifying new therapies that can target these specific genes.Could a Simple Blood Test Replace the Invasive Tissue Biopsy?
Fred Hutchinson Cancer Center
Recently presented clinical trial results showed that a commercial blood test was as effective as tissue biopsies at detecting multiple genetic mutations in lung cancer patients. However, Fred Hutchinson Cancer Research Center scientists caution that these liquid biopsies still have many challenges, like false positives. Researchers at Fred Hutch are developing a blood test to help detect lung cancer in high-risk adults whose imaging scans are inconclusive.New Brain Tumor Imaging Technique Uses Protein Found in Scorpion Venom
Cedars-Sinai Cancer
A novel imaging technique that uses a synthesized form of scorpion venom to light up brain tumors has shown promise in a clinical trial. The imaging system enables neurosurgeons to better see malignant growths that often are difficult to fully eliminate. The multi-institutional clinical trial was led by investigators from Cedars-Sinai and sponsored by Blaze Bioscience, Inc.Computational Tool Enables Powerful Molecular Analysis of Biomedical Tissue Samples
Stanford Cancer Institute
Stanford University School of Medicine researchers have invented a computational technique called CIBERSORTx that can analyze the RNA of individual cells taken from whole-tissue samples or data sets. Aaron Newman, PhD, and Ash Alizadeh, MD, PhD, are co-authors of the paper.Cancer-Focused Psychology Fellowship Receives New Accreditation
The University of Kansas Cancer Center
The University of Kansas Cancer Center’s Clinical Health Psychology fellowship program, which focuses on onco-psychology, has earned national accreditation by the American Psychological Association (APA). It is one of only 10 APA-accredited clinical health psychology fellowship programs in the U.S., and one of only two accredited programs with a sub-specialty emphasis in psychological care for cancer patients. Meagan Dwyer, PhD, and her colleagues developed the fellowship program to meet the APA’s accreditation standards.Help to Quit
University of New Mexico Comprehensive Cancer Center
A new initiative at the UNM Comprehensive Cancer Center will offer cancer patients the tools they need to quit smoking. Led by Emrullah Yilmaz, MD, PhD, Linda Cook, PhD, and Antoinette Quintana, the UNM Cancer Center Smoking Cessation Program is part of the NCI’s Cancer Center Cessation Initiative (C3I). It has started with patients who have head and neck cancers and will expand over the next two years to include all patients.Touching Base Daily Helps BMT Patients Recover More Quickly
UMMC Cancer Center and Research Institute
The ability to daily monitor a bone marrow or stem cell transplant patient once they’re home is paying dividends, say members of the University of Mississippi Medical Center Bone Marrow Transplant unit. The unit is using remote patient monitoring tools developed by the UMMC Telehealth Center that were adjusted to monitor transplant patients after they leave the hospital.Clinical Trials Collaboration Launched with Beijing Friendship Hospital
Fox Chase Cancer Center, Temple Health
Fox Chase Cancer Center and Beijing Friendship Hospital in China have initiated a collaborative agreement that will provide both institutions with added capability in cancer clinical trials. Under the agreement, Fox Chase will provide consultative services intended to enhance Beijing Friendship Hospital’s existing clinical trial capabilities. In the future, the Chinese hospital hopes to expand its own trials, while serving as a site for Fox Chase to conduct studies suitable for multiple, diverse populations.Texas Raises Tobacco Sales Age to 21
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center applauds the Texas Legislature for passing Senate Bill 21, which raises the minimum legal sale age for all tobacco products from 18 to 21. The policy, which will go into effect on September 1, 2019, is an important step toward protecting the health of future generations and reducing the burden of tobacco use in Texas.Total Cancer Care Protocol Opened to Pediatric Patients
UK Markey Cancer Center
UK HealthCare recently opened the Oncology Research Information Exchange Network’s (ORIEN) Total Cancer Care Protocol to pediatric patients, becoming the first cancer program in the country to do so. ORIEN is an alliance of 19 major cancer centers that shares information to allow its members to push forward evidence-based cancer care to patients. The University of Kentucky Markey Cancer Center joined the network in 2017.UVA Partnering to Improve HPV Vaccination Rates in Western Virginia
University of Virginia Cancer Center
University of Virginia Health System is joining a coalition of health care organizations to improve vaccination rates in western Virginia for human papillomavirus (HPV). Virginia Center for Health Innovation is partnering with 40 pediatric and family medicine sites from UVA, Ballad Health, and Carilion Clinic to boost HPV vaccinations with the support of a $225,000 grant from Merck.Cancer Center Jobs
No items found.
Meeting Announcements
11th Annual AACI CRI Meeting
July 9, 2019
The CRI annual meeting creates opportunities for peer-to-peer networking and collaboration among clinical trials office staff at AACI's member cancer centers.
SITC Women in Cancer Immunotherapy Network Leadership Institute
August 19, 2019
8:00 AM - 5:00 PM
The Society for Immunotherapy of Cancer (SITC) Women in Cancer Immunotherapy Network (WIN) Leadership Institute seeks to empower emerging female leaders in cancer immunotherapy.
Wendy & Emery Reves International Breast Cancer Symposium
September 20, 2019
8:00 AM - 5:00 PM
The Wendy & Emery Reves International Breast Cancer Symposium provides information on the latest laboratory-based translational discoveries and new technologies, while exploring developments in treatment options, clinical trials, and population sciences.
Multidisciplinary Approaches to Cancer Symposium
October 10, 2019
8:00 AM - 5:00 PM
This intensive program will provide participants with an enhanced ability to interpret and apply best treatment options into their individual cancer practices.
Cancer and Inflammation: From Micro to Macro
October 17, 2019
8:00 AM - 5:00 PM
This two-day national symposium hosted by the CCR Center of Excellence in Immunology addresses recent advances in the field through discussion and debate on the current understanding of cancer and inflammation.
2019 AACI/CCAF Annual Meeting
October 20, 2019
The CME-accredited annual meeting of the Association of American Cancer Institutes (AACI) and the Cancer Center Administrators’ Forum (CCAF) provides an opportunity to network with and learn from peers at AACI cancer centers. The meeting will cover topics of both scientific and operational value, providing attendees with practical solutions.
Artificial Intelligence in Oncology: Advancements and Policy
October 24, 2019
The inaugural Artificial Intelligence in Oncology Symposium will bring together experts in AI and machine learning as well as clinical, industry, and federal agency experts in pathology, radiology, oncology, and immuno-oncology to speak on research developments, regulatory policy, reimbursement, and ethics surrounding AI.